Radical Ventures

Radical Ventures is an early-stage venture capital firm based in Toronto, Canada, founded in 2017. The firm specializes in investing in entrepreneurs who leverage deep technology, particularly in artificial intelligence, to transform large industries. Radical Ventures focuses on making pre-seed, seed, and series A investments across various sectors, including healthcare, financial services, infrastructure, and communications. With a commitment to partnering with globally ambitious entrepreneurs, the firm aims to help build enduring companies that can have a significant impact on their respective industries. Backed by global investors, Radical Ventures is dedicated to fostering innovation and supporting the next generation of transformative businesses.

Blair Bernholtz

CFO and Partner

Aaron Brindle

Partner, Public Affairs

Edmund Clark

Partner

David Katz

Partner

Parasvil Patel

Partner

Aaron Rosenberg

Partner

Ryan Shannon

Investor

Salim Teja

Partner, Head of Velocity Team

Rob Toews

Partner

Rob Toews

Partner

Past deals in Video

Twelve Labs

Seed Round in 2022
Twelve Labs transforms video into machine-consumable form.

Virgo

Seed Round in 2018
Virgo Surgical Video Solutions, Inc. specializes in a cloud-based video recording platform tailored for the healthcare sector, particularly for gastroenterology. The company's Virgo AI platform facilitates the recording of endoscopic procedures, such as colonoscopies and upper endoscopies, while ensuring HIPAA compliance and offering secure encryption for video transfer to cloud storage. Founded in 2017 and headquartered in San Francisco, Virgo provides a cost-effective alternative to traditional methods of video capture, which relied on DVDs and thumb drives. This innovative solution not only simplifies the process of video capture and consumption but also enhances its application in patient care, quality improvement, research, and training. Additionally, Virgo's platform supports clinical trials by enabling the identification and recruitment of suitable patients for global pharmaceutical companies and academic medical centers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.